Ststent Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$58.4K
- Investors
-
2
Ststent General Information
Description
Developer of a nasal stent technology designed to promote fast healing without drugs. The company's removable technology offers precise positioning and prevents middle turbinate lateralization, enabling patients to have improved outcomes and reduced probability of revision surgeries.
Contact Information
Website
www.ststent.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
- Misgav Business Park
- 17 Tchelet Street
- Misgav 2017400
- Israel
+972 000-000-0000
Ststent Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Grant | 20-Jun-2018 | $58.4K | 00000 | Completed | Generating Revenue | |
| 3. Early Stage VC | 28-Apr-2015 | 00000 | 00000 | Completed | Generating Revenue | |
| 2. Early Stage VC | 01-Nov-2013 | $100K | $100K | Completed | Startup | |
| 1. Grant | 01-Nov-2013 | $706K | Completed | Startup |
Ststent Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a nasal stent technology designed to promote fast healing without drugs. The company's removable technology
Therapeutic Devices
Misgav, Israel
2
As of 2021
00000
0000000000
00000
000000
is aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
00000000000 0000000
Galway, Ireland
00
As of 0000
000.00
0000000000 0
000.00
00000
ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e
00000000000 0000000
Shelton, CT
000
As of 0000
00000
00000000000
00000
Add Comparison
Ststent Competitors (9)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Neurent Medical | Venture Capital-Backed | Galway, Ireland | 00 | 000.00 | 0000000000 0 | 000.00 |
| 00000 0000 | Venture Capital-Backed | Shelton, CT | 000 | 00000 | 00000000000 | 00000 |
| 000000000 000 | Formerly VC-backed | Menlo Park, CA | 000 | 00000 | 000000&0 | 00000 |
| 00000 00000 | Private Equity-Backed | Cirencester, United Kingdom | 000 | 000.00 | 000000000000 | |
| 000000 0000000 | Venture Capital-Backed | Miami, FL | 0 | 00.000 | 0000000000 0 | 00.000 |
Ststent Patents
Ststent Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10912663-B2 | Shape change structure for treatment of nasal conditions including sinusitis | Active | 26-Nov-2014 | 00000000 | 00 |
| US-20180360626-A1 | Shape change structure for treatment of nasal conditions including sinusitis | Active | 26-Nov-2014 | 00000000 | 0 |
| CA-2911226-A1 | Shape change structure | Pending | 23-May-2013 | 000000000 | |
| EP-2999493-A2 | Shape change structure | Active | 23-May-2013 | 00000000 | |
| JP-2016519972-A | Shape change structure | Active | 23-May-2013 | A61L31/14 |
Ststent Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Joseph Flomenblit Ph.D | Founder & Chief Executive Officer |
Ststent Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| Michael Berman | Self | Chairman | 000 0000 |
Ststent Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Ststent Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Horizon 2020 SME Instrument | Government | 000 0000 | 000000 0 | ||
| Trendlines | Venture Capital | Minority | 000 0000 | 000000 0 |